BridgeMD
New treatment option for Temporomandibular Disorder
Official title Electrical Stimulation of the Mandibular Nerve for Pain and Function Management in Temporomandibular Disorders
ClinicalTrials.gov ID: NCT06265636
What this study is testing
- What it's testing
- Temporomandibular disorders (TMD) encompass dysfunction and pain of the masticatory muscles and temporomandibular joint (TMJ). Pain in the TMJ, restricted jaw movement, and joint sounds are common conditions in this disorder.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Patients with local myofascial pain and/or increased tension in the masticatory muscles.
- Patients with myofascial pain from temporomandibular disorder (TMD) at the time, diagnosed according to the Research Diagnostic Criteria for...
- Absence of temporomandibular disc displacement with or without reduction.
- Pain in the masticatory muscles associated with limited mouth opening (\<40mm).
- Good general health (absence of chronic diseases that may affect the temporomandibular joint or masticatory muscles).
You likely can't join if
- Injury to the face or head during the research participation.
- Undergone surgical procedures performed in the craniocervical region and degenerative neurological diseases.
- Sudden illness of the patient that prevented participation in the study.
- Will to end participation in the study.
- Less than 2 weeks of evolution.
- Inability to understand instructions or sign the informed consent.
See the full eligibility criteria
- Patients with local myofascial pain and/or increased tension in the masticatory muscles.
- Patients with myofascial pain from temporomandibular disorder (TMD) at the time, diagnosed according to the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD).
- Absence of temporomandibular disc displacement with or without reduction.
- Pain in the masticatory muscles associated with limited mouth opening (\<40mm).
- Good general health (absence of chronic diseases that may affect the temporomandibular joint or masticatory muscles).
- Written consent to participate in the study.
- Injury to the face or head during the research participation.
- Undergone surgical procedures performed in the craniocervical region and degenerative neurological diseases.
- Sudden illness of the patient that prevented participation in the study.
- Will to end participation in the study.
- Less than 2 weeks of evolution.
- Inability to understand instructions or sign the informed consent.
- Minor patients.
- Regular medication, such as muscle relaxants, anticonvulsants, antidepressants, or anxiolytics
- Facial paralysis.
- Presenting a disease or infectious/inflammatory process of dental origin.
The study team makes the final eligibility decision.
Where it's taking place
- Alcorcón, Madrid, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Alcorcón, Madrid, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.